Prediabetes and the risk of diabetes

The Lancet

Volumn 380, Issue 9849, 2012, Pages 1225-1226

  McMurray, John J V ^a   Haffner, Steven M ^b,c   Califf, Robert M ^b,c   Holman, Rury R ^a,d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

BLOOD PRESSURE REGULATION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; LETTER; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; HUMAN; NOTE;

HUMANS; PREDIABETIC STATE;

EID: 84867032746     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61706-1     Document Type: Letter

References (2)

1. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379: 2279-90.
2. McMurray JJ, Holman RR, Haffner SM, et al, for the NAVIGATOR Study Group. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362: 1477-90.